The potential for increased rates of morbidity of SARS-CoV-2 within immunocompromised populations has been of concern since the pandemic’s onset. Transplant providers and patients can face particularly challenging situations, in the current settings as data continues to emerge for the prevention and treatment of the immunocompromised subpopulation. This case report details a patient 9-months post orthotopic heart transplant that developed SARS-CoV-2 infection despite two prior doses of the Pfizer-BioNtech COVID-19 vaccine, and had successful rescue from refractory hypoxemia with veno-venous extracorporeal membrane oxygenation (VV ECLS).
XuWSunNNGaoHN, et al.Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning. Sci Rep2021; 11(1): 1–2.
2.
Extracorporeal Life Support Organization. Extracorporeal membrane oxygenation (ECMO) in COVID-19, https://www.elso.org/COVID19.aspx (Accessed 20th February 2022).
3.
ShawTBMortonJDeschnerWP, et al.Impella 5.0: An intermediate strategy for bridging a patient from infected durable LVAD to cardiac transplant. J Cardiac Surg2022 Mar; 37(3): 685–687.
4.
XieYXuEBoweB, et al.Long-term cardiovascular outcomes of COVID-19. Nat Med2022 Mar; 28(3): 583–590.
HeldmanMRKatesOSSafaK, et al.Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic. Am J Transpl2022 Jan; 22(1): 279–288.
8.
AveryRKChiangTPMarrKA, et al.Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: a retrospective cohort. Am J Transpl2021 Jul; 21(7): 2498–2508.
9.
RinaldiMBartolettiMBussiniL, et al.COVID-19 in solid organ transplant recipients: no difference in survival compared to general population. Transpl Infect Dis2021 Feb; 23(1): e13421.
10.
LatifFFarrMAClerkinKJ, et al.Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019. J Am Med Assoc Cardiol2020 Oct 1; 5(10): 1165–1169.
11.
GrangerCGuedeneyPArnaudC, et al.Clinical manifestations and outcomes of coronavirus disease-19 in heart transplant recipients: a multicentre case series with a systematic review and meta-analysis. Transpl Intern2021 Apr; 34(4): 721–731.
12.
LacovoniABoffiniMPidelloS, et al.A case series of novel coronavirus infection in heart transplantation from 2 centers in the pandemic area in the North of Italy. J Heart Lung Transpl2020 Oct 1; 39(10): 1081–1088.
13.
CopelandHLevineDMortonJ, et al.Acute respiratory distress syndrome in the cardiothoracic patient: state of the art and use of veno-venous extracorporeal membrane oxygenation. J Thoracic Cardiovas Surg Open2021 Dec; 8: 97.
14.
AubronCDePuydtJBelonF, et al.Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation. Annals Intens Care2016 Dec; 6(1): 1–10.
15.
MalasMBNaazieINElsayedN, et al.Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. E Clinic Med2020 Dec 1; 29: 100639.
16.
KhatriAChangKMBerlinrutI, et al.Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient-case report and review of literature. J Med Mycol2021 Jun 1; 31(2): 101125.
